ASTRO 2025: Quality of Life Results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer – UroToday

Written by

admin

in

  1. ASTRO 2025: Quality of Life Results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer  UroToday
  2. Shorter radiation improves patient experience but not disease control for intermediate-risk prostate cancer, trial finds  Medical Xpress
  3. ASTRO 2025: Patient-Reported Outcomes in a Randomized Trial of 18F-Fluciclovine vs. 68Ga-PSMA-11 PET/CT- Guided Post-Prostatectomy Radiation with Simultaneous Integrated Boosts  UroToday
  4. Plenary Presentation at The ASTRO Meeting by TGH Cancer Institute Member Dr. Rodney Ellis Demonstrated That Short-course Radiation Improves Quality of Life for Men with Prostate Cancer Without Compromising Outcomes  WV News

Continue Reading

More posts